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All retroviruses contain two copies of genomic RNA that are linked noncovalently. The dimeric RNA of
human immunodeficiency virus type 1 (HIV-1) undergoes rearrangement during virion maturation, whereby
the dimeric RNA genome assumes a more stable conformation. Previously, we have shown that the packaging
of the HIV-1 polymerase (Pol) proteins reverse transcriptase (RT) and integrase (IN) is essential for the
generation of the mature RNA dimer conformation. Analysis of HIV-1 mutants that are defective in processing
of Pol showed that these mutant virions contained altered dimeric RNA conformation, indicating that the
mature RNA dimer conformation in HIV-1 requires the correct proteolytic processing of Pol. The HIV-1 Pol
proteins are multimeric in their mature enzymatically active forms; RT forms a heterodimer, and IN appears
to form a homotetramer. Using RT and IN multimerization defective mutants, we have found that dimeric RNA
from these mutant virions has the same stability and conformation as wild-type RNA dimers, showing that the
mature enzymatically active RT and IN proteins are dispensable for the generation of mature RNA dimer
conformation. This also indicated that formation of the mature RNA dimer structure occurs prior to RT or IN
maturation. We have also investigated the requirement of Pol for RNA dimerization in both Mason-Pfizer
monkey virus (M-PMV) and Moloney murine leukemia virus (MoMuLV) and found that in contrast to HIV-1,
Pol is dispensable for RNA dimer maturation in M-PMV and MoMuLV, demonstrating that the requirement
of Pol in retroviral RNA dimer maturation is not conserved among all retroviruses.
All retroviruses contain two strands of RNA that bind to-
gether noncovalently to form dimers. The evolutionary conser-
vation of genomic RNA dimerization illustrates its importance
in the retroviral life cycle (reviewed in references 19, 51, and
57). The dimeric RNA structure is one of the conformations
that human immunodeficiency virus type 1 (HIV-1) genomic
RNA assumes, and different structural motifs of retroviral ge-
nomic RNA are required at distinct stages of virus production.
Hence, RNA structures are thought to be important regulatory
elements of HIV-1 replication (12).
Dimeric RNA from several different retroviruses has been
visualized by electron microscopy and was shown to interact
near the 5 end of the genome at a region designated the dimer
linkage structure (8, 9, 33, 44). In HIV-1, a region important
for RNA dimerization termed the dimerization initiation site
(DIS) was identified through the use of short, in vitro-tran-
scribed RNA strands (14, 34, 43, 47, 65). The DIS is located
within the 5 untranslated region of the genome and forms a
hairpin structure (65). Mutations that prevent formation of the
DIS loop self-complementary region prevent the RNA dimer-
ization of in vitro-transcribed RNA strands (47, 48, 65). Dimer-
ization of genomic RNA is critical for the strand transfer of
newly synthesized viral cDNA and template switching during
reverse transcription (4, 5, 10), and probably one of the most
important functions of genomic RNA dimerization is that it
enables the recombination of retroviral genomes during re-
verse transcription (4, 5, 71). Regions of the genome involved
in RNA dimerization have also been shown to have increased
recombination, such as the dimer linkage structure of murine
leukemia virus (40) and the DIS in HIV-1 (4, 5). Therefore, the
dimeric conformation of RNA may regulate recombination
events, which are important in terms of viral fitness, enabling
increased genetic variability and rescue of reverse transcription
in the event of strand breakage.
HIV-1 RNA structural motifs have been shown to have
critical regulatory roles at multiple steps of the viral life cycle,
including translation control of HIV-1 Gag and Gag-poly-
merase (Pol) polyproteins via an RNA stem-loop to induce
ribosomal frameshifting (28) and transcriptional regulation
through the trans activation response element RNA struc-
ture (11). In addition, the HIV-1 5 untranslated region con-
tains multiple RNA structural motifs that are required for
packaging of genomic RNA (37) and reverse transcription of
viral genomic RNA (6, 7, 38). It has been proposed that HIV-1
genomic RNA can also assume alternative conformations that
serve as a switch between a translation-competent mRNA and
a dimerization and packaging-competent genomic RNA (27).
It is thought that the long-distance interaction (LDI) formed
by the translation-competent RNA masks the DIS, preventing
dimerization. Conversely, the branched multiple hairpin
(BMH) structure exposes the DIS promoting dimerization and
packaging while occluding the Gag start codon (1). In vitro
evidence suggests that the viral nucleocapsid (NC) protein
mediates the switch from LDI to BMH (27), and this illustrates
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the interplay between viral proteins and RNA conformation in
regulating steps in the replication cycle.
HIV-1 dimeric RNA undergoes structural changes during
virion assembly, packaging, and release. In vitro studies have
led to a model of RNA dimerization known as the kissing loop
model, whereby two RNA strands initially interact via their
respective DIS stem-loop structures. The kissing loop complex
is then converted into a more stable extended duplex (35, 42).
It is generally assumed that the conversion of the kissing loop
interaction (loose dimer) to the extended duplex can be
achieved by 55°C heat treatment (35, 42) or by the addition
of NC protein at physiological temperature (41, 42). The
extended duplex is often referred to as the tight dimer. This
two-step process of RNA dimerization may have relevance in
vivo, as there is evidence to suggest genomic RNA undergoes
structural changes during virion particle maturation (13, 16, 17,
45, 66, 67). Thus, the loose dimers observed in vitro are
thought to be analogous to genomic RNA dimers from imma-
ture viral particles while the tight dimers represent dimeric
RNA from mature viral particles; however, direct evidence to
support this view is currently lacking (51).
The conversion of immature HIV-1 virions to the mature
infectious viral particle requires proteolytic processing of the
precursor proteins Gag and Gag-Pol by the viral protease (32,
56). Proteolytic processing of the 55-kDa-precursor protein
Gag by the viral protease generates matrix (MA), capsid (CA),
p2 spacer peptide, NC, p1 spacer peptide, and p6Gag. The
160-kDa Gag-Pol polyprotein is cleaved into MA, CA, p2, NC,
p6Pol, the viral protease (PR), reverse transcriptase (RT) and
integrase (IN) (20). The HIV-1 Gag and Gag-Pol polypro-
teins are encoded by overlapping reading frames and are syn-
thesized at different rates. During synthesis of the Gag poly-
protein, the ribosome occasionally stalls and slips back 1
nucleotide into the Pol reading frame generating the Gag-Pol
polyprotein. This ribosomal frameshifting event results in a
20:1 ratio of Gag to Gag-Pol (28), and maintenance of the
Gag:Gag-Pol ratio is critical for RNA dimerization and viral
infectivity (60).
Formation of the mature RNA dimer conformation ob-
served in infectious retroviral particles requires proteolytic
processing of viral proteins. We have previously demonstrated
that in HIV-1, the Pol proteins RT and IN are essential for
generating the mature RNA dimer conformation in the virion
(61). Proteolytic processing of the Gag polyprotein is required
for the mature RNA dimer structure, specifically the primary
cleavage site in Gag (p2/nucleocapsid), whereas abolishing
processing at the secondary (MA/CA and p1/p6) and tertiary
(CA/p2) cleavage sites does not alter RNA dimer stability (62).
While it is clear that in HIV-1, the Pol proteins are required
for mature RNA dimer conformation, it is not known whether
RT and IN exert their effects as part of the polyprotein com-
plex or as their mature processed subunits.
In HIV-1, multimerization of RT and IN is essential for their
efficient catalytic activity. HIV-1 RT is expressed as part of the
Pr160Gag-Pol precursor, which undergoes proteolytic process-
ing to produce the RT heterodimer formed by the association
of the p66 and p51 subunits. This RT heterodimer is the form
of the enzyme biologically active with both polymerase and
RNase H activity (55, 70), while the minimal nuclear IN com-
plex is thought to be a homotetramer (36). Mutations that
prevent formation of these dimeric and tetrameric active RT
or IN protein complexes have been well characterized and
generate noninfectious virions (30). It is not known whether
the catalytic activity of these mature Pol proteins is a require-
ment for the mature RNA dimer conformation in HIV-1.
In addition to HIV-1, other retroviral RNA genomes un-
dergo conformational changes during virion maturation, in-
cluding avian leukosis virus (ALV), Rous sarcoma virus (RSV),
and Moloney murine leukemia virus (MoMuLV) (16, 17, 45,
66, 67). This maturation of virion genomic RNA requires pro-
teolytic processing of the viral polyproteins by the viral pro-
tease (16, 17, 45, 66, 67). While the mature HIV-1 RNA dimer
structure requires RT and IN, it is not known whether this
requirement for Pol proteins is conserved among all retrovi-
ruses (61).
In this study, we investigated the contribution of RT and IN
in generating the mature HIV-1 RNA dimer conformation.
RNA dimer analysis of mutants defective in Pol processing
revealed that the correct processing of Pol is critical for RNA
dimer maturation. We have also exploited mutations shown to
inhibit RT dimerization (18, 69) and IN multimerization (30)
and found no change in RNA dimer conformation from that of
wild-type (WT) dimeric RNA. This demonstrates that the ma-
ture RT and IN are dispensable for generating the mature
RNA dimer conformation in HIV-1, suggesting that the ma-
ture RNA dimer structure is formed prior to maturation of RT
or IN into their multimeric complexes. To determine whether
Pol is required for the mature RNA dimer conformation in
other retroviruses, we generated RT- and IN-deficient mutants
for two retroviruses, Mason-Pfizer monkey virus (M-PMV, a
type D retrovirus) and MoMuLV (a type-C simple retrovirus).
Analysis of virion genomic RNA in mutants lacking RT and IN
revealed that Pol is not required for the mature RNA dimer
conformation in either M-PMV or MoMuLV.
MATERIALS AND METHODS
DNA plasmids. The full-length wild-type HIV-1 plasmid referred to as NL4.3
was obtained from the AIDS Research and Reference Reagent Program, Divi-
sion of AIDS, National Institutes of Health. Additional HIV-1 constructs were
generated using stitch PCR mutagenesis whereby sequence-specific primers were
used to introduce a desired mutation (22). The region of interest was then
amplified and subcloned back into the NL4.3 backbone using relevant restriction
sites. An additional NotI site was introduced into amino acids 461 through 463
of reverse transcriptase without altering the amino acid coding sequence. This
NL4.3 RNase H (NotI) construct had wild-type levels of infectivity (data not
shown) and was also used as a wild-type backbone for subcloning. The HIV-1
protease-defective PR() has a D25N amino acid substitution (nucleotides GAT
to AAT) at the active site of the enzyme, preventing protease activity and
generating immature virions. HIV-1 GagUAA contains an additional termination
codon, which has been engineered immediately after the Gag coding region
within the Pol reading frame, which did not alter the Gag protein sequence but
prevented translation of functional PR, RT, and IN. The introduced GagUAA
termination codon is located at amino acid 15 of PR, where nucleotides ATA
have been changed to TAA, within the pol reading frame. HIV-1 PRUAG has a
termination codon (TAG) inserted immediately after the final amino acid of the
PR coding region, preventing translation of RT and IN proteins. The mutations
in HIV-1 PR(), GagUAA, and PRUAG were subcloned into the NL4.3 backbone
using ApaI and BclI restriction sites. HIV-1 RTUAG contains a termination
codon (TAG) immediately after the RT coding region, preventing translation of
IN. The mutation in HIV-1 RTUAG was subcloned into NL43 using NotI and
PflmI sites. The HIV-1 Pol processing-defective mutants (PDMs) contain addi-
tional amino acids (threonine [nucleotides ACG] and arginine [nucleotides
CGT]) inserted between the P1 and P1 residues of the RT p51-RNaseH and/or
RT-IN cleavage sites in the Pol polyprotein. Pol PDM 1 contains Thr and Arg
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codons that were inserted at the p51-RNase H cleavage site. Pol PDM 2 contains
Thr and Arg codons inserted at the RT-IN cleavage site. Pol PDM 1 and 2
mutations were subcloned into the NL4.3 RNase H (NotI) backbone using AgeI
with NotI and NotI with PflmI, respectively. Pol PDM 3 contains Thr and Arg
codon insertions at both cleavage sites and was generated by subcloning the Pol
PDM 1 AgeI –NotI insert into the Pol PDM 2 construct using AgeI and NotI
restriction sites.
The HIV-1 RT and IN proteins form multimeric complexes in their mature
forms. HIV-1 RT or IN multimerization mutants were generated by the intro-
duction of amino acid substitutions using stitch PCR mutagenesis. Mutations
L234A (18) or W401A (69) in RT and V260E (30) in IN have been reported to
prevent multimerization of RT or IN and abolish their respective enzymatic
activities. L234A (CTC to GCC) or W401A (TGG to GCG) was subcloned into
NL4.3 using BstZ17I and AgeI or AgeI and NotI sites, respectively. V260E (GTG
to GAG) was constructed using NotI and PflmI restriction sites. Once individual
clones had been generated, they were used to construct double (L234A and W401A
[LW], L234A and V260E [LV], and W401A and V260E [WV]) and triple
(L234A, W401A, and V260E [LWV]) Pol multimerization mutant clones.
Mason-Pfizer monkey virus. WT pSHRM15 and PR() were kindly provided
by Scott Parker and Eric Hunter. M-PMV PR() contains a D26N substitution
(nucleotides GAT to AAT) at the active site of the PR enzyme abolishing
protease activity. M-PMV GagUAA has an additional stop codon introduced 12
nucleotides after the WT Gag termination codon replacing nucleotides GGG to
TAA. The introduced GagUAA termination codon is situated downstream of the
first frameshift site in the Gag-Pro reading frame and prevents translation of
full-length M-PMV PR, RT, and IN. M-PMV PRUAA contains a termination
codon downstream of the PR coding sequence at amino acid 54 of RT (nucle-
otides GCA to TAA). The introduced PRUAA stop codon is 24 nucleotides after
the second frameshift site within the Pr180Gag-Pro-Pol RT reading frame prevent-
ing translation of M-PMV RT and IN. Amplified regions containing the desired
mutation were subcloned back into the pSHRM15 backbone using the BsgI and
PmlI restriction sites.
MoMuLV. MoMuLV WT pNCA was kindly provided by Stephen Goff. Mo-
MuLV mutant clones were generated by stitch PCR mutagenesis. MoMuLV
PR() contains a D32L substitution (nucleotides GAT to CTT) at the active site
of PR preventing protease activity. The readthrough event that produces Mo-
MuLV Gag-Pol is dependant on a bipartite signal consisting of a purine-rich
region immediately downstream from the Gag TAG codon (15, 25), followed by
a RNA pseudoknot structure (25). MoMuLV GagUAA contains an additional
termination codon at amino acid 18 of the PR gene (nucleotides ATA to TAA)
downstream of the readthrough RNA stem-loop structure, which prevents trans-
lation of full-length PR, RT, and IN. MoMuLV PRUAG and MoMuLV RTUAG
contain additional termination codons (TAG) inserted immediately after the PR
and RT coding regions, respectively, preventing the translation of downstream
sequences. The MoMuLV PR()-, GagUAA-, and PRUAA-amplified regions
were subcloned into the pNCA backbone using the NruI and BclI restriction
sites, while MuMoLV RTUAA was subcloned using SalI and HindIII. All regions
amplified by stitch PCR were sequenced to confirm that the desired mutations
were present and to ensure that no additional mutations were introduced.
Virus production. 293T cells (1.5  106 cells) were plated onto 10-cm-diam-
eter plates (Nunc) and maintained for 30 h in 7 ml of Dulbecco’s modified Eagle
medium (Gibco) containing 10% fetal bovine serum (P.A. Biological Co.), 100
U/ml of penicillin, and 100 g/ml of streptomycin. The production of WT and
mutant HIV-1 viral particles was achieved by transfection of 10 g of proviral
DNA into 293T cells by a calcium phosphate method as previously described
(39). An enhanced green fluorescent protein (Clontech) reporter plasmid (2 g)
was cotransfected with the HIV-1 plasmids to determine transfection efficiency.
Cells were washed twice with phosphate-buffered saline 10 h posttransfection
and maintained in fresh Dulbecco’s modified Eagle medium. Supernatants were
collected 36 h posttransfection and centrifuged at 3,000 rpm (Beckman GS-6R
centrifuge) for 30 min at 4°C to remove cellular debris.
Virion purification and protein analysis. Clarified supernatants from trans-
fected cells were purified and concentrated by ultracentrifugation through a 20%
(wt/vol) sucrose cushion using a Beckman L-90 ultracentrifuge (SW28 rotor) at
26,500 rpm for 1 h at 4°C. Virion pellets were resuspended in 250 l TE buffer
(10 mM Tris, 1 mM EDTA), pH 8.0, and 10-l samples taken for virion protein
analysis.
Analysis of virion protein profile. Virion samples (10 l) were mixed with an
equal volume of 2 Tris-buffered saline (TBS) lysis buffer containing 0.01% of
Nonidet P-40, 20 mM phenylmethylsulfonyl fluoride, 1 M pepstatin, and 1 M
leupeptin. Equal amounts of virion protein (normalized by the transfection
efficiency of enhanced green fluorescent protein) were mixed with 3 l of sample
buffer (100 mM Tris [pH 6.8], 3% sodium dodecyl sulfate [SDS], 33% glycerol,
0.03% bromophenol blue, 5 mM -mercaptoethanol), incubated for 10 min at
95°C, and resolved by SDS–10% polyacrylamide gel electrophoresis (PAGE).
Resolved proteins were transferred to a nitrocellulose membrane (Amersham)
for Western blot analysis. The membrane was blocked by washing three times in
5% skim milk dissolved in 1 TBS containing 0.3% Tween 20 and then was
probed overnight with pooled HIV-1-seropositive patient sera. After another
three washes in TBS–Tween 20 containing 5% skim milk, the membrane was
incubated with anti-human horseradish peroxidase-conjugated secondary anti-
body (Dako) for 2 h at room temperature. An enhanced chemiluminescence
technique was used for visualization of HIV-1 proteins present in the cellular
lysates (Amersham).
Analysis of virion RNA dimerization. Virion pellets resuspended in 250 l TE,
pH 8.0, were lysed by the addition of 2 RNA lysis buffer (50 mM Tris [pH 7.5],
2.5 mM EDTA [pH 8.0], 50 mM NaCl, 1% SDS, yeast tRNA at 50 g/ml,
proteinase K at 100 g/ml) and incubated for 30 min at room temperature for
proteinase K digestion. The RNA was then phenol-chloroform extracted three
times and isolated for melting curve analysis as previously described (16, 17).
Similar amounts of genomic RNA were used to analyze the stability of the virion
RNA dimer in each preparation. Samples were heated at indicated temperatures
for a period of 10 min and then chilled on ice. Dimeric and heat-denatured
monomeric RNAs were separated by electrophoresis in a 1% native agarose gel
in 0.5 Tris-borate-EDTA buffer. Samples were transferred overnight onto a
nitrocellulose Hybond N membrane (Amersham). The membrane containing the
RNA samples was air dried for 2 h at room temperature and exposed to UV light
for 90 s to induce cross-linking. Blocking of the membrane was performed for 1 h
at 42°C with 10 ml of hybridization buffer (40 ml of hybridization buffer con-
tained 8 ml of 5 SSPE [750 mM NaCl, 63 mM NaH2PO4, 0.5 mM EDTA], 20
ml of deionized formamide, 4 g of dextran sulfate, 400 l of salmon sperm DNA
[10 mg/ml], 3 ml of 20% SDS, and 5 ml of double-distilled H2O). Dimeric and
monomeric RNAs were incubated overnight with a 32P-labeled riboprobe
(pGEM7zHIV-1), which was complementary to the 5 end of the HIV-1 genomic
RNA sequences, as previously described (60). The radioactive riboprobe
was synthesized by linearizing pGEM7z HIV-1 with BamHI, followed by T7
RNA polymerase-directed in vitro transcription (Promega) in the presence of
[-32P]CTP (Amersham). After being probed, the membrane was washed
once for 30 min with 1 SSC–0.1% SDS buffer and twice for 30 min with 0.2
SSC–0.1% SDS buffer. The results were visualized by autoradiography.
RESULTS
WT HIV-1 RNA dimer structure requires the presence of RT
and IN. Using a Vpr- and Nef-defective HIV-1 construct,
HXB2-BH10, we have previously shown that an RT- and IN-
negative mutant exhibits an altered dimeric virion RNA con-
formation (61), and this defect can be rescued by supplement-
ing RT and IN into the virion particle by using Vpr-RT-IN
fusion protein (61). In this study, we used a different strain of
HIV-1, NL4.3, which expressed a functional Vpr and Nef to
verify the requirement of RT and IN in the formation of WT
virion RNA dimer conformation. HIV-1 NL4.3 WT and four
HIV-1 mutants [PR(), GagUAA, PRUAG, RTUAG] were con-
structed (Fig. 1A). HIV-1 PR() immature virions were ex-
pected to contain uncleaved viral Gag and Gag-Pol precursor
proteins, due to a D25N mutation at the active site of the viral
protease. HIV-1 GagUAA, HIV-1 PRUAG, and HIV-1 RTUAG
virion particles were designed to contain various truncated
versions of the Gag-Pol polyprotein, which was the result of the
insertion of a termination codon downstream of the stated
gene.
Western blot analyses of virion protein profiles were consis-
tent with the mutations found in these HIV-1 particles (Fig.
1B). The HIV-1 WT control revealed the proteolytic process-
ing of the Pr55Gag polyprotein into p17 matrix and p24 capsid
proteins and the cleavage of Pr160Gag-Pol into p66 RT, p51 RT,
and p32 IN (Fig. 1B, lane 2). Both HIV-1 PR() and HIV-1
GagUAA had no proteolytic activity; thus, no cleavage products
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of Gag or Gag-Pol were present in these virions (Fig. 1B, lanes
3 and 4). HIV-1 PRUAG contained a truncated Gag-Pol that
lacked RT and IN (Fig. 1B, lane 5), while HIV-1 RTUAG had
a similar protein profile as the WT control except for the
absence of IN (Fig. 1B, lane 6).
The virion genomic RNA was isolated as previously de-
scribed (16, 17, 60–62), and the virion RNAs were subjected
to heat treatment at various temperatures to dissociate the
dimeric RNA genome into monomeric form prior to elec-
trophoresis. The WT dimeric RNA genomes of HIV-1 mi-
grated as a single band in a native agarose gel (Fig. 1C, WT).
Prior to complete dissociation into monomeric RNA at 48°C,
heat treatment of WT dimeric RNA at increasing tempera-
tures generated characteristic reduced electrophoretic mobili-
ties (Fig. 1C, WT temperatures of 4, 25, 37, and 42°C). Con-
sistent with previous reports (16, 60), the immature HIV-1
RNA dimers in PR() virions were less stable and dissociated
into monomers at 37°C [Fig. 1C, PR()]. The instability of the
dimeric RNA in the PR() mutant was also evident by the
presence of monomeric RNA at 4 and 25°C [Fig. 1C, PR()].
In contrast to WT, dimeric RNA isolated from PR() had
altered mobility [Fig. 1C, compare WT and PR()]. Virion
particles that lacked Gag-Pol proteins, i.e., HIV-1 GagUAA,
contained RNA dimers with similar stabilities to HIV-1 PR()
as a significant amount of dimeric RNA had dissociated into
monomers at 37°C (Fig. 1C, GagUAA). In agreement with our
FIG. 1. HIV-1 Pol proteins RT and IN are required for RNA dimer maturation. (A) Schematic representation of HIV-1 WT and mutant
proviral DNA constructs. HIV-1 WT pDRNL4.3 was used as a control. PR() has a D25N substitution at the active site of PR1 preventing
proteolytic activity. GagUAA has a termination codon ✕ inserted immediately after the Gag coding region. PRUAG has a termination codon }
inserted at the end of PR. RTUAG has a termination codon inserted at the end of the RT Œ coding sequence. The UAA/G insertions prevent
translation of proteins located downstream. (B) Western blot analysis was performed on purified virions. Proteins were resolved by 10%
Tris-glycine SDS-PAGE and then probed with pooled sera from HIV-1-infected individuals or anti-integrase monoclonal antibodies as described
in Materials and Methods. (C) Virion RNA was resuspended in RNA dimerization buffer and heat denatured for 10 min at the indicated
temperatures. Dimers and monomers were electrophoresed in a 1% native agarose gel and Northern analysis performed using an HIV-1-specific
riboprobe.
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previous report (61), HIV-1 GagUAA contained an additional
subset of dimeric RNA with a slower mobility than the dimer-
ic RNA found in PR() immature virions (Fig. 1C, GagUAA
indicated by 3). Both HIV-1 PRUAG and HIV-1 RTUAG
virions had RNA dimer profiles distinct from those of WT,
PR(), or GagUAA. Dimeric RNAs from HIV-1 PRUAG and
RTUAG have stabilities similar to those of HIV-1 WT RNA
dimers, being completely dissociated into monomeric RNA at
48°C. However, in contrast to the HIV-1 WT RNA dimers, the
dimeric RNA derived from HIV-1 PRUAG and HIV-1 RTUAG
particles migrated as diffuse “doublets,” which were clearly
visible at lower temperatures (Fig. 1C, PRUAG and RTUAG, 4
and 25°C). The altered RNA dimer conformation seen in the
PRUAG and RTUAG mutants confirmed our previous report
that HIV-1 RT and IN are required for the formation of the
mature WT RNA dimer conformation (61), and this require-
ment is not HIV-1 strain dependant.
The correct proteolytic processing of Gag-Pol is required for
WT RNA dimer conformation. In HIV-1, proteolytic process-
ing of the retroviral polyproteins is required for virion particle
maturation (31, 56) and also facilitates the rearrangement of
virion genomic RNA into a more stable conformation (16).
Processing of Gag occurs in a sequential manner (54), with
cleavage of p2/NC in Gag, the first site cleaved in both Gag and
Gag-Pol (52, 53), being critical for generating the WT RNA
dimer conformation (62). While mutations at the Gag regions
(p2/NC, CA/p2) of Gag-Pol have little effect on RNA dimer
stability (62), the contribution of proteolytic processing of Pol
regions within Gag-Pol to RNA dimer conformation has not
been investigated. HIV-1 Pol processing-defective mutants
were constructed by insertion of threonine and arginine resi-
dues at the cleavage junctions between the p51-RNase H or
RT-IN cleavage sites to create Pol PDM 1 and Pol PDM 2,
respectively. Pol PDM 3 contained Thr and Arg insertions in
both p51-RNase H and RT-IN cleavage sites (Fig. 2A).
Virion protein profiles of the HIV-1 Pol PDMs revealed
different Gag-Pol processing defects for each mutant. WT and
all Pol PDMs displayed similar Pr55Gag processing into p24
capsid and p17 matrix (Fig. 2B, lanes 2 and 4 through 6).
However, Gag-Pol processing of these mutants was altered
such that Pol PDM 1 had low levels of IN and an undetectable
amount of RT, Pol PDM 2 had low levels of p66 and p51 RT
subunits and a small quantity of IN, and Pol PDM 3 had low
levels of RT and IN (Fig. 2B, lanes 4 through 6, respectively).
To ensure that the Pol PDMs were defective in processing
and that the virion packaging of Pol was not affected, these
PDMs have also been cloned into protease-negative con-
structs. If these processing-defective mutations affect viral
Gag-Pol packaging but not Gag-Pol processing, one would
expect that these PR() PDMs will have a defect in GagPol
packaging. Western analysis of virion Gag and Gag-Pol in
these PR() PDMs indicated that packaging was not affected
in any of these three PDMs, implying that these mutants are
truly defective in Pol processing (data not shown).
In contrast to the WT RNA dimer conformation (Fig. 2C,
WT), the RNA dimer profiles of Pol PDMs 1, 2, and 3 (Fig.
2C, PDMs 1, 2, and 3) were indistinguishable from those of
the PRUAG dimers, where dimeric RNA doublets were clear-
ly visible at 4°C and 25°C (Fig. 2C, PRUAG). These data sug-
gested that the formation of the HIV-1 WT RNA dimer con-
formation requires the correct proteolytic processing of Gag-
Pol or the stability of the Pol processing intermediate.
HIV-1 WT RNA dimer conformation occurs prior to forma-
tion of the mature RT heterodimer or IN multimer. Whether
HIV-1 RT and IN are required to be in their mature multi-
meric forms for the production of WT RNA dimer confor-
mation is unknown. By taking advantage of amino acid sub-
stitutions known to prevent formation of the mature RT
heterodimer (L234A [18], W401A [69], or the IN tetramer
V260E [30]), we were able to generate RT or IN mutants that
were defective in RT heterodimerization or IN multimeriza-
tion. The L234A mutation is located within the highly con-
served primer grip region of p66 RT, at a distance from the
dimer interface (29), and it is thought that heterodimer for-
mation is probably prevented through indirect conformational
changes in the p66 subunit (73). The W401A site is located
within the dimer interface between the p66 and p51 subunits
(69). The hydrophobic cluster containing the W401A site is
located within a tryptophan repeat motif which is highly con-
served among primate lentiviral reverse transcriptases (3). The
W401A substitution prevents both RT heterodimer formation
and reverse transcriptase activity in vitro (69). The minimum
HIV-1 IN complex required to perform integration is proposed
to be a homotetramer (36, 72) or even an octomer (21, 36).
The V260E mutation within the C-terminal domain of IN pre-
vents the multimerization of IN, and this mutant is unable to
support viral integration (30).
Western blot analysis revealed that HIV-1 virions containing
the single RT L234A substitution had undetectable RT or IN,
indicating possible Gag-Pol instability (Fig. 3B, lane 2). This
was consistent with a previous report showing that mutation at
the L234 site reduces the stability of the Gag-Pol precursor,
resulting in a 20-fold decrease of RT and IN found in mutant
virions (76). As Gag-Pol packaging is required for forming the
WT RNA dimer conformation, most of the mutants containing
L234A were excluded from RNA dimer analysis, except the
triple LWV mutant that was used as a negative control. The
RT W401A mutant had a similar virion protein profile in
comparison with WT HIV-1 (Fig. 3B, lanes 1 and 3), whereas
the IN V260E mutant profile contained both RT subunits but
no IN was detected (Fig. 3B, lane 4). This indicated that the
p66 and p51 RT monomers were stable, while multimerization
of IN might be required to stabilize the mature IN in the virion.
The combination of RT W401A and IN V260E mutations
(WV) resulted in the same RT and IN defective protein pro-
files as the single V260E mutant (Fig. 3B, lanes 4 and 7).
Although W401A and V260E mutations prevent the multi-
merization of RT and IN, respectively, they are unlikely to
prevent Gag-Pol interaction, shown by the presence of cor-
rectly processed Gag and RT subunits in the virion protein
profile for both single and double mutants (Fig. 3B, lanes 3, 4,
and 7).
As expected, the LWV triple multimerization mutant (Fig.
3C, LWV) had an RNA dimer conformation different from
WT and similar to PRUAG (Fig. 1C, PRUAG), which is most
likely attributed to the lack of RT or IN in these virions. RNA
dimer analysis of single multimerization mutants RT W401A,
IN V260E, and double multimerization mutant RT W401A
and IN V260E (WV) revealed RNA dimer profiles indistin-
guishable from those of HIV-1 WT (Fig. 3C, WT, W401A,
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V260E, WV). These results indicated that generation of the
WT RNA dimer conformation was independent of RT dimer-
ization or the presence of mature IN, implying that the re-
quirement of Pol for WT RNA dimer structure occurs prior to
RT or IN maturation.
The requirement of RT and IN in WT RNA dimer structure
is not conserved among all retroviruses. We have used M-
PMV, a prototype of type D retroviruses that assembles intra-
cellularly, and MoMuLV, a prototype of a simple type C ret-
rovirus, to determine if RT and IN proteins are required for
WT RNA dimer conformation in other retroviruses by using a
series of M-PMV (Fig. 4A) and MoMuLV (Fig. 4B) mutants.
M-PMV and MoMuLV protease-negative mutants were gen-
erated by an amino acid substitution at the active site of the
viral protease. Truncated versions of Pol were generated for
each virus by introducing additional termination codons within
the Pol gene to prevent the translation of downstream protein
sequences. M-PMV and MoMuLV GagUAA mutants were un-
able to translate PR, RT, or IN proteins, whereas M-PMV
PRUAA and MoMuLV PRUAG mutants lacked RT or IN pro-
teins. The MoMuLV RTUAG mutant produced no IN protein.
The cleavage site between the M-PMV RT and IN proteins has
not been identified; consequently an RTUAA mutant was not
generated for M-PMV.
FIG. 2. The impact of Pol-processing mutations on HIV-1 virion protein composition and genomic RNA dimer maturation. (A) Schematic
representation of HIV-1 and Pol PDMs 1, 2, and 3 is given. Constructs were generated by insertion of Thr and Arg codons into the indicated
cleavage sites by PCR mutagenesis. Pol PDM 1 had a Thr and Arg insertion between the RT p51-RNase H cleavage site indicated by [ ] Pol
PDM 2 contains Thr and Arg at the RT-IN cleavage site indicated by [ ] Pol PDM 3 contained Thr and Arg insertions at both p51-RNase H
and RT-IN cleavage sites indicated by [ ]. (B) Western blot analysis was performed on WT, PRUAG (lacking in Pol proteins), and Pol PDMs
1, 2, and 3. Proteins from purified virions were resolved by 10% Tris-glycine SDS-PAGE and then probed with pooled sera from HIV-1-infected
individuals. (C) Virion RNA was resuspended in RNA dimerization buffer and heat denatured for 10 min at the indicated temperatures. Dimers
and monomers were electrophoresed in a 1% native agarose gel and probed with an HIV-1-specific riboprobe as described in Materials and
Methods.
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Western analysis of M-PMV WT and PRUAA virions (Fig.
4C, lanes 1 and 4) revealed normal proteolytic processing of
the Gag precursor into capsid. MoMuLV WT virions con-
tained the Gag cleavage products, and MoMuLV PRUAG viri-
ons contained partially processed Gag as well as capsid, impli-
cating the presence of MoMuLV PR in the MoMuLV PRUAG
mutant (Fig. 4D, lanes 1 and 4). The MoMuLV RTUAG mu-
tant (Fig. 4D, lane 5) revealed normal Gag processing. Virion
protein profiles of M-PMV PR() and GagUAA (Fig. 4C, lanes
2 and 3) and MoMuLV PR() and GagUAA (Fig. 4D, lanes 2
and 3) revealed an absence of proteolytic processing as ex-
pected. Both M-PMV PRUAA and MoMuLV PRUAG mutants
are unlikely to express RT or IN, whereas the MoMuLV
RTUAG mutant is predicted to lack IN.
M-PMV and MoMuLV do not require Pol proteins for WT
RNA dimer conformation. Both M-PMV WT and M-PMV
PRUAA RNA dimers dissociated into monomers after heat
treatment at 48°C (Fig. 4E, WT and PRUAA). As M-PMV
PRUAA was not expected to express RT and IN, these data
suggested that Pol is dispensable for WT RNA dimer confor-
mation in this virus. M-PMV PR() and GagUAA RNA dimers
were less stable than WT and had altered electrophoretic mo-
bilities [Fig. 4E, PR(-) and GagUAA], which is consistent with
reports on other PR() retroviral species such as HIV-1 (16),
MoMuLV (17), RSV (45), and ALV (66) where proteolytic
processing of viral precursor proteins is critical for WT RNA
dimer structure and stability. Similar to WT HIV-1 dimeric
RNA, both M-PMV WT and M-PMV PRUAA RNA dimers
FIG. 3. The effect of HIV-1 Pol multimerization-defective mutants on RNA dimer maturation. (A) Schematic representation of HIV-1 proviral
DNA constructs containing amino acid substitutions at the indicated sites that prevent RT dimerization is given: L234A (L) and W401A (W) or
IN multimerization V260E (V). Further combinations of these substitutions were also generated. (B) Western blot analysis was performed on
purified virions. Proteins were resolved by 10% Tris-glycine SDS-PAGE and then probed with pooled sera from HIV-1-infected individuals.
(C) RNA dimer analysis was performed on WT, PR() (which contains an inactive protease), W401A, and V260E single mutants; the W401A and
V260E double mutant (WV); and the L234A, W401A, and V260E triple mutant (LWV). Virion RNA was resuspended in RNA dimerization buffer
and heat denatured for 10 min at the indicated temperatures. Dimers and monomers were electrophoresed in a 1% native agarose gel and probed
with an HIV-1-specific riboprobe.
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exhibited characteristic reduced electrophoretic mobilities
when the samples were treated at 4°C, 25°C, 37°C, and 42°C. It
appeared that the MoMuLV WT dimeric RNA was fraction-
ally more stable than MoMuLV PR(), GagUAA, PRUAG, and
RTUAG RNA dimers shown by the majority of WT RNA
remaining dimeric post-heat treatment at 48°C (Fig. 4F, see
arrows at 48°C for each panel). In contrast to HIV-1 and
M-PMV, the difference in electrophoretic mobility between
MoMuLV WT and mutant virion RNA dimers was more sub-
tle than that for RNA dimers seen with HIV-1 and M-PMV.
These data do not support the requirement of Pol in the
production of WT RNA dimers in M-PMV and MoMuLV.
FIG. 4. Mason-Pfizer monkey virus and Moloney murine leukemia virus do not require RT and IN for WT RNA dimer conformation. (A and
B) Schematic representation of M-PMV and MoMuLV proviral DNA constructs, respectively. PR() contained an amino acid substitution at the
active site of PR (1), preventing proteolytic activity. GagUAA contained termination codon in the PR reading frame immediately after Gag (X),
preventing translation of PR or the Pol proteins. PRUAA and PRUAG had termination codons at the ends of their respective PR (}) coding regions.
MoMuLV RTUAG had a termination codon end of RT (Œ), preventing translation of the IN enzyme. Western blot analysis was performed on
purified virions for M-PMV (C) and MoMuLV (D). Proteins were resolved by 10% Tris-glycine SDS-PAGE and then probed with appropriate
anti-Gag antibody. Virion RNA was resuspended in RNA dimerization buffer and heat denatured for 10 min at the indicated temperatures. Dimers
and monomers were electrophoresed in a 1% native agarose gel and probed with a M-PMV (E) or MoMuLV (F)-specific riboprobe.
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DISCUSSION
We have shown that the requirement for RT and IN in the
formation of the mature HIV-1 RNA dimer conformation is
not strain dependant. We have also demonstrated that the
correct proteolytic processing of the HIV-1 Pol proteins is
essential for RNA dimer maturation. However, an enzymati-
cally active RT or IN is not required for RNA dimer confor-
mation, which suggests that RNA dimer maturation is com-
pleted prior to formation of the mature multimeric RT or IN
proteins. RT and IN are not required for WT RNA dimer
conformation in M-PMV and Mo-MuLV, showing that the
requirement of Pol for generating the mature RNA dimer
structure is not conserved among all retroviruses.
Our NL43 HIV-1 dimeric RNA from WT, PR(), GagUAA,
and PRUAG virions exhibits the same stability and mobility
profiles as those of our previously published HxB2-BH10 con-
structs (61). Our previous report utilized a Vpr-supplement
system to provide Vpr-RT, Vpr-IN, or Vpr-RT-IN in trans to
an RT- and IN- deficient mutant (PRUAA). Only supplemen-
tation with Vpr-RT-IN was able to restore RNA dimer con-
formation to that of the WT (61). Consistent with our previous
report, our HIV-1 RTUAG mutant is insufficient to yield a WT
RNA dimer structure in the absence of IN (61). As the Gag/
Gag-Pol ratio is important for RNA dimerization (60, 63), we
utilized the RTUAG system to ensure that our previously ob-
served impact of Pol protein in RNA dimerization was not
biased by the altered levels of RT or IN that were introduced
into the virion via the Vpr supplement system (75).
Having established that Pol is critical for generating the
mature RNA dimer conformation, we speculated on the bio-
logical significance of this RNA structure in retroviral replica-
tion. The altered RNA conformation seen in mature retroviral
particles including HIV-1, ALV, RSV, MoMuLV, and addi-
tionally, M-PMV (16, 17, 45, 66, 67) is likely to be a prereq-
uisite for subsequent steps in the viral replication cycle. The
importance of the rearrangement of the genomic RNA dimers
during virion maturation is supported by the fact that it is a
conserved feature in all in vivo RNA dimer maturation studies
thus far (16, 17, 45, 66, 67). The obvious candidate for requir-
ing a specific RNA conformation is to support the synthesis of
viral cDNA from the genomic RNA template. This process is
particularly likely, considering that the factors required for
RNA dimer conformation, such as genomic RNA, RT, and IN
(74), are all part of the ribonucleoprotein reverse transcription
complex. In addition, it has been established that RNA dimer-
ization is required for the first strand transfer step of reverse
transcription (10).
Processing of the HIV-1 viral polyproteins during virion
maturation is a highly regulated event, and alteration of this
process can cause severe defects in virion assembly, RNA
dimerization, and infectivity. Until now, the importance of the
proteolytic processing of Pol in RNA dimer conformation has
not been investigated. By disrupting Pol processing through
the introduction of Thr and Arg residues into Pol cleavage
junctions, we showed that the correct processing of the HIV-1
Pol proteins RT and IN is essential in generating mature RNA
dimers that exhibit the same stability and mobility as those of
WT RNA. The doublets seen in PRUAG mutants may repre-
sent a heterogeneous population of dimeric RNA or an inter-
mediate immature conformation that occurs prior to formation
of the WT mature conformation. Processing of Gag-Pol may
induce a rearrangement of genomic RNA that positions the
genomic RNA, RT, and IN into the ribonucleoprotein initia-
tion complex. As enzymatically active RT or IN is not required
for RNA dimer maturation, the formation of the mature RNA
dimer conformation is likely to occur prior to maturation of the
RT or IN protein complexes.
The biological necessity of the mature WT RNA dimer con-
formation may also be related to the effects of RNA dimeriza-
tion on the synthesis of viral cDNA during reverse transcrip-
tion. HIV-1 DIS mutations that impair RNA dimerization
have also been shown to reduce DNA synthesis around the
second strand transfer step, though the mechanism for this is
unknown (49, 64). DIS mutants are capable of forming dimeric
virion RNA, but these dimers have an altered conformation to
that of the WT (23). The finding that HIV-1 DIS is required
for viral infectivity in a T-cell line (49) but not in peripheral
blood mononuclear cells suggests the involvement of a novel
host cell factor in peripheral blood mononuclear cells that is
able to compensate for the role of DIS in RNA dimerization to
support HIV-1 replication (23). Perhaps the requirement of
this host cell factor may in part regulate the RNA dimeric struc-
ture to support the synthesis of viral cDNA during infection.
Although the DIS is thought to be one of the primary re-
gions involved in RNA dimerization (34, 47, 65), other as yet
undefined regions of the genomic RNA are also likely to be
involved. Studies showing DIS mutants with WT RNA stability
in vivo suggest that other regions are involved in the dimer-
ization of genomic RNA (2, 23, 58, 59). In addition, internal
regions of genomic RNA can negatively affect RNA dimeriza-
tion (59). This may be to prevent the formation of an incor-
rectly folded dimeric RNA structure. The altered RNA con-
formation seen in WT mature virions as opposed to that in
immature virions may be reflective of dimerization occurring at
additional regions within the genomic RNA.
The genomic RNA dimer conformation in M-PMV has not
been investigated previously; here, we show for the first time
that the WT RNA dimer conformation in M-PMV requires
proteolytic processing of the viral polyproteins, consistent with
other retroviruses (16, 17, 45, 66, 67). Our MoMuLV WT RNA
dimers are more stable than dimeric RNA from PR() mu-
tants when subjected to melting point analysis, which is con-
sistent with previous reports (17). The limitations of our RNA
dimer analysis technique made it difficult to clearly differenti-
ate between MoMuLV WT and mutant RNA dimer profiles.
The requirement of RT and IN for WT RNA dimer confor-
mation in HIV-1 is not conserved among all retroviruses,
namely, M-PMV and MoMuLV. This may be a reflection of
the requirements of complex (HIV-1) versus simple (M-PMV
and MoMuLV) retroviruses. Alternatively, the lack of require-
ment of Pol for RNA dimer structure in MoMuLV and M-
PMV may reflect the limitations of our current mobility-based
system for the analysis of RNA dimer structure. Development
of more direct analysis of virion RNA dimer structure will be
essential to define the significance of RNA dimer conforma-
tion in retroviral replication. A chemical-based RNA probing
technique has recently been described to dissect the secondary
structure of the HIV-1 viral RNA genome (50), and such
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technique will undoubtedly provide important clues in defining
the precise RNA structure of the dimeric viral RNA genome.
The importance of RNA dimer conformation in mediating
events in the viral life cycle is illustrated by the proposed LDI
to BMH switch (26, 27, 46). These two different RNA confor-
mations formed within the 5 leader region are thought to
regulate the progression from a translation-competent mRNA
to the dimerization and packaging-competent genomic RNA
(12). The relevance of these in vitro-derived structures needs
to be analyzed in an in vivo system, and thus the need for
ultrastructural studies on full-length genomic RNA. RNA re-
gions involved in dimerization in the virion could potentially be
identified through the use of the RNA cross-linking agent
psoralen, which forms covalent bonds between dimerized RNA
strands when exposed to long-wave UV light (68) and then
subsequent visualization of the dimeric RNA by electron mi-
croscopy as previously described (24). Analysis of RNA ultra-
structure by electron microscopy would provide a direct means
of analyzing the interacting regions of HIV-1 RNA and pro-
vide insights into RNA dimer structure. Elucidation of the di-
meric structure of HIV-1 RNA would also aid in determining
the role of RNA conformation in reverse transcription and
other steps in the viral replication cycle.
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